Surgeons treating patients with degenerative disc disease may now use a new stand-alone intervertebral body fusion device recently cleared by the Food and Drug Administration. Manufactured by Binder Biomedical Inc., the device presents a complete anterior lumbar fixation system with a simple, one-step locking mechanism.
Called LOGIC™, the system is designed for use in a direct anterior surgical approach for accessing the intervertebral disc space of the patient’s lumbar spine. The alpha release is expected in the first quarter of 2014. The nationwide launch is expected by the fourth quarter of 2014.
Binder Biomedical President Lawrence Binder said: “We are excited to bring such a streamlined device to market. Our design team has done a great job putting together such a comprehensive system, ensuring that it can be tailored to any surgeon’s preferred surgical technique.”
Each implant is designed with a large central window for optimum autograft bone placement. Size offerings range from 10 to 20 mm in height, and all devices have an anatomically-shaped lordotic angle that matches the convex curvature of the vertebral endplates. The LOGIC™ devices are implanted into the intervertebral space and then three screws are placed through the device, into the vertebrae to provide stabilization and facilitate fusion.
The design team leader is Mark Testaiuti (MD, FAANS) a spine neurosurgeon at Coastal Spine, in Mt. Laurel, N.J. “Working with the Binder team on the LOGIC™ system,” he said, “has been a rewarding and satisfying experience. Their responsiveness and attention to detail separates Binder from other companies I have worked with.”